Organigram Holdings Inc. Gross Margin

Gross Margin of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Margin growth rates and interactive chart. Gross profit margin shows the percentage of revenue that exceeds a company's costs of goods sold. It illustrates how well a company is generating revenue from the costs involved in producing their products and services. The higher the margin, the more effective the company's management is in generating revenue for each dollar of cost. Gross profit margin is calculated by subtracting the cost of goods sold from total revenue for the period and dividing that number by revenue. If a company has $200 million in revenue and $80 million in cost of goods sold, the gross margin is 60%.

Highlights and Quick Summary

  • Gross Margin for the quarter ending February 28, 2023 was 25.07% (a -54.53% decrease compared to previous quarter)
  • Year-over-year quarterly Gross Margin increased by 25.04%
  • Annual Gross Margin for 2022 was 21.65% (a -160.36% decrease from previous year)
  • Annual Gross Margin for 2021 was -35.87% (a -44.88% decrease from previous year)
  • Annual Gross Margin for 2020 was -65.08% (a -207.96% decrease from previous year)
  • Twelve month Gross Margin ending February 28, 2023 was 33.32% (a -2.89% decrease compared to previous quarter)
  • Twelve month trailing Gross Margin increased by 110.75% year-over-year
Trailing Gross Margin for the last four month:
28 Feb '23 30 Nov '22 31 Aug '22 31 May '22
33.32% 34.31% 21.65% 15.81%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Margin of Organigram Holdings Inc.

Most recent Gross Marginof OGI including historical data for past 10 years.

Interactive Chart of Gross Margin of Organigram Holdings Inc.

Organigram Holdings Inc. Gross Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 25.07% – – – –
2022 55.14% 31.59% 20.05% 28.49% 21.65%
2021 2.01% 10.31% 10.43% -117.43% -35.87%
2020 -86.26% -153.97% -278.65% 48.61% -65.08%
2019 44.5% -70.84% -0.72% 29.55% 60.28%
2018 – – 416.0% 100.0% 422.39%
2017 – – – – -43.38%
2016 – – – – 82.08%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com